Unknown

Dataset Information

0

Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).


ABSTRACT: The aim of this study was to assess the influence of pro-inflammatory interleukin (IL)-1 genotype status on the risk for coronary artery disease (CAD), defined as >50% diameter stenosis, and cardiovascular events mediated by oxidized phospholipids (OxPLs) and lipoprotein (Lp) (a).OxPLs are pro-inflammatory, circulate on Lp(a), and mediate CAD. Genetic variations in the IL-1 region are associated with increased inflammatory mediators.IL-1 genotypes, OxPL on apolipoprotein B-100 (OxPL/apoB), and Lp(a) levels were measured in 499 patients undergoing coronary angiography. The composite genotype termed IL-1(+) was defined by 3 single-nucleotide polymorphisms in the IL-1 gene cluster associated with higher levels of pro-inflammatory cytokines. All other IL-1 genotypes were termed IL-1(-).Among IL-1(+) patients, the highest quartile of OxPL/apoB was significantly associated with a higher risk for CAD compared with the lowest quartile (odds ratio [OR]: 2.84; p = 0.001). This effect was accentuated in patients age ?60 years (OR: 7.03; p < 0.001). In IL-1(-) patients, OxPL/apoB levels showed no association with CAD. The interaction was significant for OxPL/apoB (OR: 1.99; p = 0.004) and Lp(a) (OR: 1.96; p < 0.001) in the IL-1(+) group versus the IL-1(-) group in patients age ?60 years but not in those age >60 years. In IL-1(+) patients age ?60 years, after adjustment for established risk factors, high-sensitivity C-reactive protein, and Lp(a), OxPL/apoB remained an independent predictor of CAD. IL-1(+) patients above the median OxPL/apoB presented to the cardiac catheterization laboratory a mean of 3.9 years earlier (p = 0.002) and had worse 4-year event-free survival (death, myocardial infarction, stroke, and need for revascularization) compared with other groups (p = 0.006).Our study suggests that IL-1 genotype status can stratify population risk for CAD and cardiovascular events mediated by OxPL. These data suggest a clinically relevant biological link between pro-inflammatory IL-1 genotype, oxidation of phospholipids, Lp(a), and genetic predisposition to CAD and cardiovascular events.

SUBMITTER: Tsimikas S 

PROVIDER: S-EPMC4008715 | biostudies-literature | 2014 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).

Tsimikas Sotirios S   Duff Gordon W GW   Berger Peter B PB   Rogus John J   Huttner Kenneth K   Clopton Paul P   Brilakis Emmanuel E   Kornman Kenneth S KS   Witztum Joseph L JL  

Journal of the American College of Cardiology 20140212 17


<h4>Objectives</h4>The aim of this study was to assess the influence of pro-inflammatory interleukin (IL)-1 genotype status on the risk for coronary artery disease (CAD), defined as >50% diameter stenosis, and cardiovascular events mediated by oxidized phospholipids (OxPLs) and lipoprotein (Lp) (a).<h4>Background</h4>OxPLs are pro-inflammatory, circulate on Lp(a), and mediate CAD. Genetic variations in the IL-1 region are associated with increased inflammatory mediators.<h4>Methods</h4>IL-1 geno  ...[more]

Similar Datasets

| S-EPMC10824318 | biostudies-literature
| S-EPMC11298641 | biostudies-literature
| S-EPMC4956483 | biostudies-literature
| S-EPMC3770094 | biostudies-literature
| S-EPMC6902165 | biostudies-literature
| S-EPMC3882224 | biostudies-literature
| S-EPMC6494952 | biostudies-literature
| S-EPMC3475437 | biostudies-literature
| S-EPMC3485195 | biostudies-literature
| S-EPMC4479336 | biostudies-literature